Fennec Pharmaceuticals Inc (FENC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fennec Pharmaceuticals Inc   (NASDAQ: FENC)


Fennec Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fennec Pharmaceuticals Inc's ROI in the second quarter of 2026?
Fennec Pharmaceuticals Inc recorded a cumulative net loss of $-3 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -5.76%.

Within the Healthcare sector 215 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3071 to 3140.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 36.48 % 7.8 % -15.25 % -18.48 % 9.15 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 63 62 60 40 37
Return On Investment (TTM) -5.76 % -16.85 % -22.31 % -12.96 % -24.33 %
FENC's Overall Ranking # 3140 # 3071 # 2831 # 0 # 0
Seq. Investment Change TTM 13.41 % 13.86 % 14.19 % -7.44 % -10.42 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -8 -10 -5 -10

FENC Company Profile >> Back to FENC Roi Comparisons >> See Annual FENC Return On Investment



Return On Investment FENC's Ranking
Within: No.
Industry # 22
Sector # 216
Overall # 3140

Return On Investment Statistics
High Average Low
142.18 %
-115.51 %
-2135.68 %
(Sep 30 2015)   (Dec 31 2012)







Financial Statements
Fennec Pharmaceuticals Inc's II. Quarter Investments $ 63 Millions FENC's Balance sheet
Fennec Pharmaceuticals Inc's II. Quarter Income $ 2 Millions Quarterly FENC's Income Statement
FENC's Income by Division See FENC's Income by Division


FENC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 35 38 20 23 21
Y / Y Investment Growth -7.39 % 92.74 % -12.75 % 9.66 % -28.5 %
Net Income in Millions -10 0 -16 -24 -17
Y / Y Net Income Growth - - - - -
Annual Return On Investment -27.44 % -1.14 % -80.68 % -104.05 % -83.46 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FENC's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FENC's Competitors
Subscribers only: Roi for Fennec Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for FENC's Customers

Other Ratios
FENC's Roa FENC's Inventory Turnover Ratio FENC's Growth Rates FENC's Dividend Statistics
FENC's Profitability Ratios FENC's Asset Turnover Ratio FENC's Dividend Growth
FENC's Roe FENC's Valuation Ratios FENC's Financial Strength Ratios FENC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:11:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.